One Patient Submitted $9.1M In 2024 Employer Health Claims

Employer health plans are seeing a lot more participants with very high costs, according to a new report from Lockton.

The firm runs an employer plan database that holds information on 882 employer groups and 3.9 million plan participants.

One of the plan participants submitted $9.15 million in claims in 2024, and nine others submitted more than $4 million in claims, according to the firm’s analysis of the plan data.

Lockton has not published the actual rate of patients with very high claims per 1 million plan enrollees per year.

But it says that the odds that a patient would have $1 million to $2 million in annual claims increased by 45% between 2022 and 2024.

The odds that a patient would have $2 million or more in annual claims increased by 47%.

One culprit was a big increase in the cost of caring for people with cancer.

The average cost of chemotherapy for cancer climbed to $12.61 per member per month in 2024, from $4.53 per member per month in 2023.

The backdrop: The new Lockton report adds to evidence that U.S. patients are using more care.

Fitch recently cited an increasing need for care as a reason to adopt a negative outlook for the entire U.S. health insurance sector.

Sun Life U.S. sells stop-loss insurance, or arrangements that protect employers’ self-funded health plans against catastrophic losses.

Sun Life U.S. reported the number of patients at its customers’ plans who had annual claims of $1 million or more increased 29% between 2023 and 2024, to 221 $1million-plus claims per 1 million plan participants.

A physician’s views: Dr. Shealynn Buck, the chief medical officer at Lockton, said during a video presentation posted by the firm that she believes that the increase in U.S. patients’ need for care is affecting physicians, hospitals, pharmaceutical manufacturers and other players in the U.S. health care system, as well as employers and other payers.

“All health care stakeholders are feeling this squeeze,” Buck said. “Everybody’s really trying to protect their margins.”

One solution is for employers and other payers to focus more on wellness and health plan participant use of health screenings, to keep people healthy and to prevent small problems from leading to $1 million claims, Buck said.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square